Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
1.865
-0.035 (-1.84%)
Nov 13, 2026, 4:00 PM EST - Market closed
Genelux Revenue
Genelux had revenue of $8.00K in the twelve months ending June 30, 2026. In the year 2025, Genelux had annual revenue of $8.00K. That makes Genelux the 47,322nd largest company in the world by revenue and 7,184th in the United States.
Revenue (ttm)
$8.00K
Revenue Growth
n/a
P/S Ratio
10,446.80
Revenue / Employee
$308
Employees
26
Market Cap
83.57M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.00K | - | - |
| Dec 31, 2024 | 8.00K | -162.00K | -95.29% |
| Dec 31, 2023 | 170.00K | -10.90M | -98.46% |
| Dec 31, 2022 | 11.07M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Black Diamond Therapeutics | 70.00M |
| Coherus Oncology | 53.64M |
| Seer, Inc. | 14.08M |
| Cibus | 4.53M |
| Rallybio | 434.00K |
GNLX News
- 1 month ago - Genelux assumed with a Buy at Lucid Capital - TheFly
- 2 months ago - Genelux publishes case report from dose escalation portion of OLVI-VEC-202-SCLC - TheFly
- 2 months ago - Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy - GlobeNewsWire
- 2 months ago - Genelux reports Q2 EPS (21c), consensus (20c) - TheFly
- 2 months ago - Genelux expects cash to fund operations into Q1 of 2027 - TheFly
- 2 months ago - Genelux reports Q2 EPS (21c), consensus (20c) - TheFly
- 3 months ago - Genelux Corporation Reports Second Quarter Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Genelux Quarterly report: Q2 2026 - Filings